Maternal Cardiac Disease and Perinatal Outcomes in a Single Tertiary Care Center

Abstract

Objective This study aims to compare the perinatal outcomes of pregnant women with heart disease and a healthy pregnant control group, as well as the maternal and newborn outcomes of pregnant women with congenital heart disease and acquired heart disease.

Material method Pregnant women with heart disease and healthy control pregnant women were included in this retrospective study. Sociodemographic data of all patients included in the study were obtained from electronic records. Perinatal outcomes of all patients were compared.

Results A total of 258 pregnant women were included in the study. While 129 pregnant women were diagnosed with heart disease, 129 patients were low-risk pregnant women. Preeclampsia (p=0.004) and cesarean section (p=0.01) rates were higher in pregnant women with heart disease compared to healthy pregnant women. Compared with healthy pregnant women, pregnant women with heart disease had a lower birth weight (p=0.003), a higher fetal growth restriction (FGR) rate (p=0.036), lower birth percentiles (p=0.002), a lower 5-minute APGAR (p=0.0001), a higher neonatal intensive care unit (NICU) admission rate (p=0.001), and a longer NICU stay rate (p=0.001). The mean gestational age at birth of pregnant women with congenital heart disease was higher than that of those with acquired heart disease (p=0.017).

Conclusion It was observed that all maternal heart diseases were associated with adverse perinatal outcomes compared to healthy pregnant women. In this series, perinatal adverse outcomes of pregnant women with congenital and acquired heart disease did not differ. Keywords: acquired heart disease, congenital heart disease, pregnancy

Keywords

acquired heart disease - congenital heart disease - pregnancy

Publication History

Received: 07 December 2023

Accepted: 11 April 2024

Article published online:
03 June 2024

• References

• 1 Campbell DA. An Update on the United Nations Millennium Development Goals. J Obstet Gynecol Neonatal Nurs 2017; 46: e48-e55 DOI: 10.1016/j.jogn.2016.11.010.
• 2 Owens A, Yang J, Nie L. et al. Neonatal and maternal outcomes in pregnant women with cardiac disease. J Am Heart Assoc 2018; 7: e009395
• 3 Hidano G, Uezono S, Terui K. A retrospective survey of adverse maternal and neonatal outcomes for parturients with congenital heart disease. Int J Obstet Anesth 2011; 20: 229-235 DOI: 10.1016/j.ijoa.2011.03.005.
• 4 Goya M, Casellas M, Merced C. et al. Predictors of obstetric complications in women with heart disease. J Matern Fetal Neonatal Med 2016; 29: 2306-2311
• 5 Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol 2020; 17: 718-731
• 6 Roos-Hesselink J, Baris L, Johnson M. et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J 2019; 40: 3848-3855 DOI: 10.1093/eurheartj/ehz136.
• 7 Lima FV, Yang J, Xu J. et al. national trends and in-hospital outcomes in pregnant women with heart disease in the United States. Am J Cardiol 2017; 119: 1694-1700 DOI: 10.1016/j.amjcard.2017.02.003.
• 8 Tsaitlin-Mor L, Nir A, Elchalal U. et al. Outcomes of pregnancy and delivery in women with cardiac disease compared to matched healthy controls. J Matern Fetal Neonatal Med 2022; 35: 5821-5827 DOI: 10.1080/14767058.2021.1895739.
• 9 Goldstein SA, Ward CC. Congenital and acquired valvular heart disease in pregnancy. Curr Cardiol Rep 2017; 19: 96 DOI: 10.1007/s11886-017-0910-6.
• 10 Baghel J, Keepanasseril A, Pillai AA. et al. Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease. Heart 2020; 106: 1400-1406
• 11 Hameed A, Karaalp IS, Tummala PP. et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001; 37: 893-899 DOI: 10.1016/s0735-1097(00)01198-0.
• 12 Gonzalez JM, Harris I, Jimenez Ramirez N. et al. Maternal cardiac disease and perinatal outcomes in a single tertiary care center. J Matern Fetal Neonatal Med 2023; 36: 2223336 DOI: 10.1080/14767058.2023.2223336.
• 13 Silversides CK, Grewal J, Mason J. et al. Pregnancy outcomes in women with heart disease: The CARPREG II Study. J Am Coll Cardiol 2018; 71: 2419-2430 DOI: 10.1016/j.jacc.2018.02.076.
• 14 Drenthen W, Boersma E, Balci A. et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010; 31: 2124-2132 DOI: 10.1093/eurheartj/ehq200.
• 15 Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J. et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39: 3165-3241 DOI: 10.1093/eurheartj/ehy340.
• 16 Kim YY, Goldberg LA, Awh K. et al. Accuracy of risk prediction scores in pregnant women with congenital heart disease. Congenit Heart Dis 2019; 14: 470-478 DOI: 10.1111/chd.12750.
• 17 Balci A, Sollie-Szarynska KM, van der Bijl AG. et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart 2014; 100: 1373-1381 DOI: 10.1136/heartjnl-2014-305597.
• 18 Lu CW, Shih JC, Chen SY. et al. Comparison of 3 risk estimation methods for predicting cardiac outcomes in pregnant women with congenital heart disease. Circ J 2015; 79: 1609-1617 DOI: 10.1253/circj.CJ-14-1368.
• 19 Pijuan-Domènech A, Galian L, Goya M. et al. Cardiac complications during pregnancy are better predicted with the modified WHO risk score. Int J Cardiol 2015; 195: 149-154 DOI: 10.1016/j.ijcard.2015.05.076.
• 20 ACOG Practice Bulletin No. 212 Pregnancy and Heart Disease. Obstet Gynecol 2019; 133: e320-e356 DOI: 10.1097/aog.0000000000003243.
• 21 Vause S, Clarke B. Heart disease in pregnancy. Br J Hosp Med (Lond) 2012; 73: 319-323 DOI: 10.12968/hmed.2012.73.6.319.
• 22 Gabriel Altit M, Leduc L, Dallaire F. Pregnancies with maternal heart disease: small babies, big problems?. Can J Cardiol 2021; 37: 1908-1909
• 23 Roos-Hesselink JW, Ruys TP, Stein JI. et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 2013; 34: 657-665
• 24 Silversides CK, Grewal J, Mason J. et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol 2018; 71: 2419-2430
• 25 Siu SC, Sermer M, Colman JM. et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104: 515-521
• 26 Bhatla N, Lal S, Behera G. et al. Cardiac disease in pregnancy. Int J Gynaecol Obstet 2003; 82: 153-159
• 27 Ueland K, Novy MJ, Metcalfe J. Hemodynamic responses of patients with heart disease to pregnancy and exercise. Am J Obstet Gynecol 1972; 113: 47-59
• 28 Hameed AB, Lawton ES, McCain CL. et al. Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. Am J Obstet Gynecol 2015; 213: 379.e371-379.e310
• 29 Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the US. J Am Coll Cardiol 2009; 54: 460-467
• 30 Koutrolou-Sotiropoulou P, Parikh PB, Miller C. et al. Impact of heart disease on maternal and fetal outcomes in pregnant women. Am J Cardiol 2015; 116: 474-480
• 31 Wald RM, Silversides CK, Kingdom J. et al. Maternal cardiac output and fetal doppler predict adverse neonatal outcomes in pregnant women with heart disease. J Am Heart Assoc 2015; 4: e002414
• 32 Lima FV, Koutrolou-Sotiropoulou P, Parikh PB. et al. Pregnant women with heart disease: placental characteristics and their association with fetal adverse events. Acute Card Care 2016; 18: 56-64
• 33 Moons P, Bovijn L, Budts W. et al. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 2010; 122: 2264-2272 DOI: 10.1161/circulationaha.110.946343.
• 34 Siu SC, Colman JM. Heart disease and pregnancy. Heart 2001; 85: 710-715
• 35 Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 2001; 98: 28-35
• 36 Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001; 87: 295-298
• 37 Yentis S, Steer P, Plaat F. Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998; 105: 921-922
• 38 Oberhänsli I, Extermann P, Jaggi E. et al. Fetal echocardiography in pregnancies of women with congenital heart disease-clinical utility and limitations. Thorac Cardiovasc Surg 2000; 48: 323-327
• 39 Gei AF, Hankins GD. Cardiac disease and pregnancy. Obstet Gynecol Clin North Am 2001; 28: 465-512
• 40 Owens A, Yang J, Nie L. et al. Neonatal and maternal outcomes in pregnant women with cardiac disease. J Am Heart Assoc 2018; 7: e009395 DOI: 10.1161/jaha.118.009395.
• 41 Greutmann M, Pieper PG. Pregnancy in women with congenital heart disease. Eur Heart J 2015; 36: 2491-2499 DOI: 10.1093/eurheartj/ehv288.
• 42 Drenthen W, Pieper PG, Roos-Hesselink JW. et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49: 2303-2311
• 43 Drenthen W, Boersma E, Balci A. et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010; 31: 2124-2132